REAL-WORLD EFFECTIVENESS OF E-CIGARETTES: A POPULATION STUDY
Jamie Brown*, Ph.D., 1,2, Emma beard, Ph.D., 1, Daniel Kotz, Ph.D., 1,3, Susan Michie, D.Phil., 2, 4, Robert West, Ph.D., 1, 4 1 Cancer Research UK Health Behaviour Research Centre, University College London, WC1E 6BT, UK 2 Department of Clinical, Educational and Health Psychology, University College London, London, UK 3 Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, the Netherlands 4 National Centre for Smoking Cessation and Training, London, UK
Background: Electronic cigarettes (e-cigarettes) are rapidly increasing in popularity. Two randomised controlled trials have suggested that e-cigarettes can aid smoking cessation but there are many factors that could influence their real-world effectiveness. This study aimed to assess, using an established methodology, the effectiveness of e-cigarettes compared with nicotine replacement therapy (NRT) bought over-the-counter and with unaided quitting in the general population. Methods: A large survey of a representative sample of the English population. The study included 5726 adults who had smoked within the previous 12 months and made at least one quit attempt during that period with either an e-cigarette only (n=391), NRT bought over-the-counter only (n=2031) or no aid in their most recent quit attempt (n=3304). The primary outcome measure was self-reported abstinence up to the time of the survey, adjusted for key potential confounders including nicotine dependence. Results: E-cigarette users were more likely still to be abstinent than either those who used NRT bought over-the-counter (OR=223, 95%CI=167- 297, 199% vs. 100%) or no aid (OR=140, 95%CI=107-182, 199% vs. 151%). The adjusted odds of non-smoking in users of e-cigarettes were 166 (95%CI=117-236) times higher compared with users of NRT bought over-the-counter and 160 (95%CI=115-223) times higher compared with those using no aid. Conclusion: Among smokers stopping without professional support, those who use e-cigarettes appear more likely to be able to remain abstinent than those who use a licensed NRT product bought over-the-counter or no aid to cessation. This difference persists after adjusting for a wide range of smoker characteristics such as nicotine dependence.
FUNDING: JBs post is funded by a fellowship from the UK Society for the Study of Addiction. RW is funded by Cancer Research UK. We are grateful to Cancer Research UK, the Department of Health and Pfizer for funding this study. This study is partly funded by Pfizer under an investigator initiated award.
Jamie Brown*, Ph.D., 1,2, Emma beard, Ph.D., 1, Daniel Kotz, Ph.D., 1,3, Susan Michie, D.Phil., 2, 4, Robert West, Ph.D., 1, 4 1 Cancer Research UK Health Behaviour Research Centre, University College London, WC1E 6BT, UK 2 Department of Clinical, Educational and Health Psychology, University College London, London, UK 3 Department of General Practice, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, the Netherlands 4 National Centre for Smoking Cessation and Training, London, UK
Background: Electronic cigarettes (e-cigarettes) are rapidly increasing in popularity. Two randomised controlled trials have suggested that e-cigarettes can aid smoking cessation but there are many factors that could influence their real-world effectiveness. This study aimed to assess, using an established methodology, the effectiveness of e-cigarettes compared with nicotine replacement therapy (NRT) bought over-the-counter and with unaided quitting in the general population. Methods: A large survey of a representative sample of the English population. The study included 5726 adults who had smoked within the previous 12 months and made at least one quit attempt during that period with either an e-cigarette only (n=391), NRT bought over-the-counter only (n=2031) or no aid in their most recent quit attempt (n=3304). The primary outcome measure was self-reported abstinence up to the time of the survey, adjusted for key potential confounders including nicotine dependence. Results: E-cigarette users were more likely still to be abstinent than either those who used NRT bought over-the-counter (OR=223, 95%CI=167- 297, 199% vs. 100%) or no aid (OR=140, 95%CI=107-182, 199% vs. 151%). The adjusted odds of non-smoking in users of e-cigarettes were 166 (95%CI=117-236) times higher compared with users of NRT bought over-the-counter and 160 (95%CI=115-223) times higher compared with those using no aid. Conclusion: Among smokers stopping without professional support, those who use e-cigarettes appear more likely to be able to remain abstinent than those who use a licensed NRT product bought over-the-counter or no aid to cessation. This difference persists after adjusting for a wide range of smoker characteristics such as nicotine dependence.
FUNDING: JBs post is funded by a fellowship from the UK Society for the Study of Addiction. RW is funded by Cancer Research UK. We are grateful to Cancer Research UK, the Department of Health and Pfizer for funding this study. This study is partly funded by Pfizer under an investigator initiated award.